Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO
Prospective Randomized Pilot Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric Extracorporeal Membrane Oxygenation
Sponsor: University of Texas Southwestern Medical Center
This PHASE4 trial investigates Anticoagulants and Extracorporeal Membrane Oxygenation Complication and is currently completed. University of Texas Southwestern Medical Center leads this study, which shows 12 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Feb 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Apr 2022 — Feb 2023 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Mar 2021 — Apr 2022 [monthly]
Recruiting PHASE4
▶ Show 7 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE4
-
Nov 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Apr 2020 — Nov 2020 [monthly]
Recruiting PHASE4
-
Oct 2019 — Apr 2020 [monthly]
Recruiting PHASE4
-
Sep 2018 — Oct 2019 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Not Yet Recruiting PHASE4
-
Nov 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Texas Southwestern Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .